Innoscience: Approaching a Critical Profitability Inflection, Market Underappreciating Execution Path

Core Thesis

Innoscience is at a pivotal financial turning point. Its IDM model, coupled with aggressive capacity expansion and deepening customer engagements, positions it to potentially double its gross margin to over 15% in 2026 from 7.3% in 2025, while supporting an ~85% revenue surge. The market likely underappreciates the pace of this margin improvement, its strategic position within the NVIDIA ecosystem for future 800V data center adoption, and the cost benefits from its scaled manufacturing roadmap.

What the Market May Be Mispricing

Current sentiment may not fully price the feasibility and speed of the company's margin trajectory toward its long-term target of 45-50% gross margin. Furthermore, partnerships with over half of NVIDIA's power suppliers are not yet valued as a tangible path to future orders within the 800V architecture transition. Lastly, the scale and cost-down potential from the planned capacity ramp from 20k to 70k wafers-per-month (wpm) are likely under-discounted.

Evidence Chain

A Clear Profitability Inflection and Aggressive Long-Term Targets. Management's guidance points to a definitive gross margin expansion to 15%+ in 2026, more than doubling the 7.3% achieved in 2025. This sets the stage for its long-term target of 45-50% gross margin and 25-30% net margin at full utilization of 70k wpm capacity. The investment implication is a rapid narrowing of operating losses, with profitability potentially turning in 2027.

Capacity Expansion Underpins Growth and Cost Reduction. The company's roadmap is capital-intensive but clear: capacity will scale from 20k wpm in 2025 to 30-35k wpm by end-2026/early-2027, and to 70k wpm by end-2027/early-2028. This planned tripling of capacity over three years is critical to support the guided 2026 revenue of RMB 2.0-2.5 billion (~85% growth) and to drive the fixed cost absorption necessary for margin expansion. Execution against this timeline is the primary growth lever.

Customer Breakthroughs and Multi-Engine Growth. Beyond consumer applications, Innoscience is securing design-ins across high-growth verticals. Its cooperation with more than half of NVIDIA's power suppliers is a key strategic foothold for the eventual shift to 800V data center power systems. Concurrently, it is gaining orders from automotive, humanoid robotics, and appliance customers. This diversification de-risks the growth narrative and provides multiple paths to fill the expanding capacity.

Key Divergences and Risks

The adoption of GaN in 800V data centers requires a system architecture change, which could delay volume ramp and NVIDIA-related orders. Competitive capacity additions could intensify, pressuring pricing and market share. Penetration into new fields like EVs and robotics may slow if GaN's cost-benefit equation does not improve as expected.

Valuation and Trading Implications

The investment case hinges on validating the margin improvement and capacity ramp. Achieving the 2026 gross margin target of 15%+ would be a critical proof point for the business model and support valuation re-rating. The current price of HK$52.60 implies a discount to the stated price target of HK$69.00 (based on 26x 2026e P/S), reflecting market skepticism over this execution path. Monitoring quarterly gross margin progression and customer qualification announcements will be key.

Appendix: Key Data Summary

Innoscience Capacity Expansion Roadmap